Not a shareholder here but saw RAC mentioned while I was digging into ME1 so thought I’d share the positivity (the same can’t be said for me1 unfortunately).
looks like your old director Daniel tillet really did you guys a solid and set up nice foundations for the team.
The site I was looking at highlighted his on-market buying which definitely caught my eye.
Full linkhere (https://www.raretriples.com.au/case-studies/race-oncology-july-2023), can’t say I’ve seen too many examples of this size of support. The website also complements the number of shareholder questions he answered. This kind of stuff definitely doesn’t happen enough.
congrats to those who backed this all early. Would be nice for such role model companies to be highlighted more often.
RAC Masterclass
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.095(7.22%) |
Mkt cap ! $234.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.41 | $1.32 | $249.8K | 182.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2826 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.37 |
Change
0.095 ( 6.64 %) |
||||
| Open | High | Low | Volume | ||
| $1.34 | $1.41 | $1.32 | 16145 | ||
| Last updated 15.53pm 10/05/2024 ? | |||||
| RAC (ASX) Chart |